Temas de la conferencia From Dissecting Mechanisms of Epithelial Dysfunction to Discovering Patient Reported Outcomes for More Meaningful Clinical Trials, Uncover Scientific Advancements and Actionable Insights to Optimize IPF Drug Development
Returning with a revitalized agenda including 25 brand new speakers, the hotly anticipated two-tracked summit is back!
Organizador profesional (PCO) Hanson Wade
Observaciones Speakers: Andrei Gudkov Chief Science Officer Genome Protection, Andrew Thorley Fibrosis Therapeutic Area Lead - OMNI Biomarker Development Genentech, Anjaly Pandey Senior Vice President of Nonclinical and Chemistry twoXAR Pharmaceuticals and more
